Atmosphere1 / Shutterstock.com
21 November 2019Big PharmaSaman Javed
EU General Court sides with Merck in TM opposition
A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Europe
14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.
Editor's picks
Editor's picks
Europe
14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.
Europe
14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.